Switch to
More onapp

Medicamen Biotech Ltd

MEDICAMEQ
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,244 cr, stock is ranked 953
High RiskStock is 3.60x as volatile as Nifty
1,025.5542.15 (+4.29%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,244 cr, stock is ranked 953
High RiskStock is 3.60x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
83.44
PB RatioPB Ratio
8.49
Dividend YieldDiv. Yield
0.10%
Sector PESector PE
34.97
Sector PBSector PB
4.27
Sector Div YldSctr Div Yld
0.92%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

MEDICAMEN Biotech is engaged in manufacturing of pharmaceutical formulations.

Investor PresentationView older 

Dec 4, 2021

PDF
View Older Presentations

Financial TrendFinancial statements 

2019202020212022126.26127.44113.47117.1712.0313.2912.1314.91
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Closure of trading window 
Announced OnOct 1, 2022

Medicamen Biotech Limited has informed the Exchange about Closure of trading window | Download

Medicamen Biotech Limited has informed the Exchange about Closure of trading window | Download

Annual General Meeting 
Announced OnSep 28, 2022

Medicamen Biotech Limited has informed the Exchange about Voting results and Scrutinizer report of Annual General Meeting held on 27-Sep-2022 | Download

Medicamen Biotech Limited has informed the Exchange about Voting results and Scrutinizer report of Annual General Meeting held on 27-Sep-2022 | Download

Cash Dividend 
Ex. DateSep 19, 2022

Final • Div/Share: ₹ 1

See all events